167 related articles for article (PubMed ID: 32118311)
1. CircRNA_103762 promotes multidrug resistance in NSCLC by targeting DNA damage inducible transcript 3 (CHOP).
Xiao G; Huang W; Zhan Y; Li J; Tong W
J Clin Lab Anal; 2020 Jun; 34(6):e23252. PubMed ID: 32118311
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of circRNA_100876 Inhibited Progression of NSCLC In Vitro via Targeting miR-636.
Song J; Shi W; Gao Z; Liu X; Wang W
Technol Cancer Res Treat; 2020; 19():1533033820951817. PubMed ID: 33030101
[TBL] [Abstract][Full Text] [Related]
3. CircRNA_010763 promotes growth and invasion of lung cancer through serving as a molecular sponge of miR-715 to induce c-Myc expression.
Zhang P; Xue XF; Ling XY; Yang Q; Yu Y; Xiao J; Wang ZN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7310-7319. PubMed ID: 32706069
[TBL] [Abstract][Full Text] [Related]
4. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
6. SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.
Li J; Zhao L; Pan Y; Ma X; Liu L; Wang W; You W
Int J Oncol; 2020 Sep; 57(3):756-766. PubMed ID: 32705243
[TBL] [Abstract][Full Text] [Related]
7. CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.
Li Y; Zhang J; Pan S; Zhou J; Diao X; Liu S
Thorac Cancer; 2020 Mar; 11(3):537-548. PubMed ID: 31917898
[TBL] [Abstract][Full Text] [Related]
8. CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT/ERK1/2 signaling.
Qiu BQ; Zhang PF; Xiong D; Xu JJ; Long X; Zhu SQ; Ye XD; Wu Y; Pei X; Zhang XM; Wu YB
J Cell Physiol; 2019 Jul; 234(7):11256-11264. PubMed ID: 30565694
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression.
Zhang H; Wang X; Hu B; Zhang F; Wei H; Li L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3410-3416. PubMed ID: 31407591
[TBL] [Abstract][Full Text] [Related]
10. CircRNA_001010 adsorbs miR-5112 in a sponge form to promote proliferation and metastasis of non-small cell lung cancer (NSCLC).
Wang Q; Kang PM
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4271-4280. PubMed ID: 32373963
[TBL] [Abstract][Full Text] [Related]
11. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC.
Li YH; Xu CL; He CJ; Pu HH; Liu JL; Wang Y
Mol Carcinog; 2020 Feb; 59(2):141-153. PubMed ID: 31749230
[TBL] [Abstract][Full Text] [Related]
12. Circ_0000003 promotes the proliferation and metastasis of non-small cell lung cancer cells via miR-338-3p/insulin receptor substrate 2.
Li S; Niu X; Li H; Liang Y; Sun Z; Yan Y
Cell Cycle; 2019 Dec; 18(24):3525-3539. PubMed ID: 31736412
[No Abstract] [Full Text] [Related]
13. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression.
Wan J; Hao L; Zheng X; Li Z
Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639
[TBL] [Abstract][Full Text] [Related]
14. CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-145.
Yang H; Zhao M; Zhao L; Li P; Duan Y; Li G
Cell Oncol (Dordr); 2020 Jun; 43(3):477-488. PubMed ID: 32297303
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circ‑ACACA regulates proliferation, migration and glycolysis in non‑small‑cell lung carcinoma via miR‑1183 and PI3K/PKB pathway.
Wu W; Xi W; Li H; Yang M; Yao X
Int J Mol Med; 2020 Jun; 45(6):1814-1824. PubMed ID: 32236577
[TBL] [Abstract][Full Text] [Related]
16. circHIPK3 Acts as Competing Endogenous RNA and Promotes Non-Small-Cell Lung Cancer Progression through the miR-107/BDNF Signaling Pathway.
Hong W; Zhang Y; Ding J; Yang Q; Xie H; Gao X
Biomed Res Int; 2020; 2020():6075902. PubMed ID: 33015172
[TBL] [Abstract][Full Text] [Related]
17. miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP).
Tan W; Liao Y; Qiu Y; Liu H; Tan D; Wu T; Tang M; Zhang S; Wang H
Cancer Lett; 2018 Aug; 428():55-68. PubMed ID: 29702190
[TBL] [Abstract][Full Text] [Related]
18. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p.
Wei S; Zheng Y; Jiang Y; Li X; Geng J; Shen Y; Li Q; Wang X; Zhao C; Chen Y; Qian Z; Zhou J; Li W
EBioMedicine; 2019 Jun; 44():182-193. PubMed ID: 31160270
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p.
Luo S; Shen M; Chen H; Li W; Chen C
Mol Med Rep; 2020 Nov; 22(5):3822-3832. PubMed ID: 32901838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
